scholarly journals Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder

2018 ◽  
Vol 24 (3) ◽  
pp. S41-S42 ◽  
Author(s):  
Susan E. Prockop ◽  
Ai Li ◽  
Robert Baiocchi ◽  
Nancy J. Bunin ◽  
Kris Michael Mahadeo ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document